Hypertriglyceridemia: Clinical Trials

2 trials for Hypertriglyceridemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Terminated 2

Follow Hypertriglyceridemia: new trials by email Literature Review of Hypertriglyceridemia trials Research Report on Hypertriglyceridemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of LY3875383 in Healthy Participants and Participants With Hypertriglyceridemia
LY3875383, Placebo - Hypertriglyceridemia
Phase 1TerminatedEli Lilly and Company412022-11-142025-06-04
A First in Human Study of STT-5058, an Antibody That Binds ApoC3
STT-5058, Placebo - Hypertriglyceridemia
Phase 1TerminatedStaten Biotechnology BV932020-05-262023-01-23

Broader conditions

Dyslipidemias (2)  ·  Hyperlipidemias (2)  ·  Lipid Metabolism Disorders (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)

Sponsors

Eli Lilly and Company (1)  ·  Staten Biotechnology BV (1)

Countries

Singapore (1)  ·  United Kingdom (1)